Literature DB >> 30765903

Prescribing for transgender patients.

Louise Tomlins1.   

Abstract

Entities:  

Keywords:  gender dysphoria; gonadal steroid hormones; transgender persons

Year:  2019        PMID: 30765903      PMCID: PMC6370611          DOI: 10.18773/austprescr.2019.003

Source DB:  PubMed          Journal:  Aust Prescr        ISSN: 0312-8008


× No keyword cloud information.
  4 in total

1.  Australian standards of care and treatment guidelines for transgender and gender diverse children and adolescents.

Authors:  Michelle M Telfer; Michelle A Tollit; Carmen C Pace; Ken C Pang
Journal:  Med J Aust       Date:  2018-06-18       Impact factor: 7.738

2.  The health and well-being of transgender high school students: results from the New Zealand adolescent health survey (Youth'12).

Authors:  Terryann C Clark; Mathijs F G Lucassen; Pat Bullen; Simon J Denny; Theresa M Fleming; Elizabeth M Robinson; Fiona V Rossen
Journal:  J Adolesc Health       Date:  2014-01-14       Impact factor: 5.012

3.  Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.

Authors:  Wylie C Hembree; Peggy T Cohen-Kettenis; Louis Gooren; Sabine E Hannema; Walter J Meyer; M Hassan Murad; Stephen M Rosenthal; Joshua D Safer; Vin Tangpricha; Guy G T'Sjoen
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

4.  Interpreting laboratory results in transgender patients on hormone therapy.

Authors:  Tiffany K Roberts; Colleen S Kraft; Deborah French; Wuyang Ji; Alan H B Wu; Vin Tangpricha; Corinne R Fantz
Journal:  Am J Med       Date:  2013-10-19       Impact factor: 4.965

  4 in total
  1 in total

1.  Population pharmacokinetics of tenofovir, emtricitabine and intracellular metabolites in transgender women.

Authors:  Asama Tanaudommongkon; Ayyappa Chaturvedula; Craig W Hendrix; Edward J Fuchs; Eugenie Shieh; Rahul P Bakshi; Mark A Marzinke
Journal:  Br J Clin Pharmacol       Date:  2022-03-25       Impact factor: 3.716

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.